Jeanny B. Aragon-Ching, MD, FACP, discusses how new guidelines have changed the treatment of advanced metastatic bladder cancer.
Browsing: Bladder
Aman Chauhan, MBBS, University of Kentucky shares Telotristat for Carcinoid Syndrome Diarrhea | Wish for More Trials, Products, Pipeline Drugs…
Aman Chauhan, MBBS, University of Kentucky shares Data Showed Diarrhea From Chemotherapy at Annual Meeting 2018
Aman Chauhan, MBBS, University of Kentucky explains enterade® is a Medical Food | Does Not Need Formal Prescription. OTC at…
Aman Chauhan, MBBS, University of Kentucky explains enterade® Amino Acid Based Rehydration Solution | 70% of Patients Had Benefit in…
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Target Tumors More Effectively | Better Combinations, Find…
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Annual Meeting Helps Impact Ability to Communicate |…
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Moving Toward Precision Medicine | Field is Growing…
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Bladder Cancer is No Longer Just One Disease…
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation…
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Studies for Fibroblast Growth Factors Receptors | Mutations…
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a…
Petros Grivas, MD, PhD, University of Washington talks about Dynamic Era of Changes for Urothelial Cancer | Data with FGFR…
Petros Grivas, MD, PhD, University of Washington talks about Whether Genomic Alterations Have Significance | And-Or Predict Response to Individual…
Petros Grivas, MD, PhD, University of Washington talks about Circulating Tumor DNA as a Putative Biomarker | For Patients with…